| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
1,722 |
1,140 |
$1.01M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,556 |
2,341 |
$114K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,497 |
2,350 |
$102K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,477 |
1,419 |
$87K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
593 |
277 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,334 |
1,915 |
$66K |
| 92134 |
|
4,051 |
2,969 |
$44K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,061 |
739 |
$27K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
442 |
363 |
$23K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
576 |
542 |
$20K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
327 |
314 |
$14K |
| 92136 |
|
1,269 |
947 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
112 |
93 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
315 |
209 |
$4K |
| Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg |
26 |
13 |
$2K |
| 92015 |
Determination of refractive state |
750 |
630 |
$1K |
| 92133 |
|
80 |
78 |
$1K |
| 92083 |
|
25 |
24 |
$389.39 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
134 |
132 |
$0.00 |
| 99072 |
|
20 |
17 |
$0.00 |
| 1036F |
|
159 |
156 |
$0.00 |